Your browser doesn't support javascript.
loading
Q-122 as a novel, non-hormonal, oral treatment for vasomotor symptoms in women taking tamoxifen or an aromatase inhibitor after breast cancer: a phase 2, randomised, double-blind, placebo-controlled trial.
Vrselja, Amanda; Latifi, Ardian; Baber, Rodney J; Stuckey, Bronwyn G A; Walker, Michael G; Stearns, Vered; Hickey, Martha; Davis, Susan R.
Afiliación
  • Vrselja A; QUE Oncology, Melbourne, VIC, Australia. Electronic address: avrselja@queoncology.com.
  • Latifi A; QUE Oncology, Melbourne, VIC, Australia.
  • Baber RJ; Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia.
  • Stuckey BGA; Keogh Institute for Medical Research, Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, School of Medicine, University of Western Australia, Nedlands, WA, Australia.
  • Walker MG; Walker Bioscience, Carlsbad, CA, USA.
  • Stearns V; Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Hickey M; Department of Obstetrics and Gynaecology, University of Melbourne and the Royal Women's Hospital, Melbourne, VIC, Australia.
  • Davis SR; Women's Health Research Program, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia; Department of Endocrinology and Diabetes, Alfred Health, Melbourne, VIC, Australia.
Lancet ; 400(10364): 1704-1711, 2022 Nov 12.
Article en En | MEDLINE | ID: mdl-36366886
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Inhibidores de la Aromatasa Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Female / Humans / Male Idioma: En Revista: Lancet Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Inhibidores de la Aromatasa Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Female / Humans / Male Idioma: En Revista: Lancet Año: 2022 Tipo del documento: Article